The Cigna Group (CI) Financials

$311.83 +0.97 (+0.31%)

Closing price 03:59 PM Eastern

Extended Trading

$309.83 -2.00 (-0.64%)

As of 07:25 PM Eastern

Annual Income Statements for The Cigna Group

This table shows The Cigna Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Net Income / (Loss) Attributable to Common Shareholders	3,434	5,164	6,704	5,370	8,458	5,104	2,637	2,237	1,867
Consolidated Net Income / (Loss)	3,778	5,372	6,782	5,420	8,489	5,120	2,646	2,232	1,843
Net Income / (Loss) Continuing Operations	3,778	5,372	6,782	5,420	8,489	5,120	2,646	2,232	1,843
Total Pre-Tax Income	5,269	5,513	8,397	6,790	10,868	6,570	3,581	3,606	2,979
Total Revenue	244,408	193,688	181,693	174,126	164,554	153,741	48,569	41,722	39,838
Net Interest Income / (Expense)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Interest Income	244,408	193,688	181,693	174,126	164,554	153,741	48,569	41,722	39,838
Net Realized & Unrealized Capital Gains on Investments	-1,740	-411	2,330	1,606	5,397	1,565	1,399	-84	-
Premiums Earned	45,996	44,237	39,916	41,154	42,627	39,714	36,113	-	-
Other Non-Interest Income	200,152	149,862	139,447	131,366	116,530	112,462	11,057	41,806	39,838
Total Non-Interest Expense	237,704	186,729	172,068	166,128	152,248	145,489	44,490	37,864	36,859
Property & Liability Insurance Claims	38,648	36,287	32,184	33,565	32,710	30,819	27,528	25,263	24,341
Other Operating Expenses	197,353	148,623	138,008	130,565	117,556	111,721	16,727	12,486	12,367
Amortization Expense	1,703	1,819	1,876	1,998	1,982	2,949	235	115	151
Nonoperating Income / (Expense), net	-1,435	-1,446	-1,228	-1,208	-1,438	-1,682	-498	-252	-
Income Tax Expense	1,491	141	1,615	1,370	2,379	1,450	935	1,374	1,136
Net Income / (Loss) Attributable to Noncontrolling Interest	344	208	78	50	31	16	9.00	-5.00	-24
Basic Earnings per Share	$12.25	$17.57	$21.66	$15.89	$23.17	$13.58	$10.69	$8.92	$7.31
Weighted Average Basic Shares Outstanding	273.68M	292.36M	297.06M	320.95M	351.85M	375.80M	246.70M	250.89M	-
Diluted Earnings per Share	$12.12	$17.39	$21.41	$15.75	$22.96	$13.44	$10.54	$8.77	$7.19
Weighted Average Diluted Shares Outstanding	273.68M	292.36M	297.06M	320.95M	351.85M	375.80M	246.70M	250.89M	-
Weighted Average Basic & Diluted Shares Outstanding	273.68M	292.36M	297.06M	320.95M	351.85M	375.80M	246.70M	250.89M	-
Cash Dividends to Common per Share	$5.60	$4.92	$4.48	$4.00	$0.04	$0.04	$0.04	$0.04	$0.00

This table shows The Cigna Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	1,323	1,424	739	1,548	-277	1,029	1,408	1,460	1,267	1,193	2,757
Consolidated Net Income / (Loss)	1,409	1,536	825	1,629	-212	1,107	1,449	1,510	1,306	1,222	2,778
Net Income / (Loss) Continuing Operations	1,409	1,536	825	1,629	-212	1,107	1,449	1,510	1,306	1,222	2,778
Total Pre-Tax Income	1,648	2,009	1,192	1,989	79	188	1,840	1,884	1,601	1,358	3,491
Total Revenue	65,543	65,847	62,686	60,475	55,400	49,602	49,013	48,612	46,461	45,364	46,934
Net Interest Income / (Expense)	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Interest Income	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Interest Expense	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Non-Interest Income	65,543	65,847	62,686	60,475	55,400	49,602	49,013	48,612	46,461	45,364	46,934
Net Realized & Unrealized Capital Gains on Investments	279	475	-923	273	-1,565	-1,222	286	304	221	-	1,857
Premiums Earned	12,736	11,503	11,436	11,454	11,603	11,175	10,998	11,039	11,025	-	9,586
Other Non-Interest Income	52,528	53,869	52,173	48,748	45,362	39,649	37,729	37,269	35,215	25,223	35,491
Total Non-Interest Expense	63,533	63,476	61,118	58,111	54,999	49,054	46,808	46,365	44,502	43,383	43,139
Property & Liability Insurance Claims	10,498	10,166	9,527	9,515	9,440	9,280	8,927	9,034	9,046	7,969	7,751
Other Operating Expenses	52,611	52,886	51,155	48,176	45,136	39,323	37,427	36,876	34,997	34,957	34,928
Amortization Expense	422	424	436	420	423	451	454	455	459	457	460
Other Special Charges	2.00	-	-	-	-	-	-	-	-	-	-
Nonoperating Income / (Expense), net	-362	-362	-376	-375	-322	-360	-365	-363	-358	-	-304
Income Tax Expense	239	473	367	360	291	-919	391	374	295	136	713
Net Income / (Loss) Attributable to Noncontrolling Interest	86	112	86	81	65	78	41	50	39	29	21
Basic Earnings per Share	$4.88	$5.06	$2.65	$5.51	($0.97)	$3.54	$4.79	$4.96	$4.28	$3.89	$9.07
Weighted Average Basic Shares Outstanding	267.14M	273.68M	278.15M	279.55M	284.07M	292.36M	292.62M	295.98M	295.87M	297.06M	305.74M
Diluted Earnings per Share	$4.85	$5.01	$2.63	$5.45	($0.97)	$3.49	$4.74	$4.92	$4.24	$3.82	$8.97
Weighted Average Diluted Shares Outstanding	267.14M	273.68M	278.15M	279.55M	284.07M	292.36M	292.62M	295.98M	295.87M	297.06M	305.74M
Weighted Average Basic & Diluted Shares Outstanding	267.14M	273.68M	278.15M	279.55M	284.07M	292.36M	292.62M	295.98M	295.87M	297.06M	305.74M
Cash Dividends to Common per Share	$1.51	-	$1.40	$1.40	$1.40	-	$1.23	$1.23	$1.23	-	$1.12

This table details how cash moves in and out of The Cigna Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Net Change in Cash & Equivalents	594	2,361	428	-4,697	4,834	1,556	907	-213	1,217
Net Cash From Operating Activities	10,363	11,813	8,656	7,191	10,350	9,485	3,770	4,086	4,026
Net Cash From Continuing Operating Activities	10,363	11,813	8,656	7,191	10,350	9,485	3,770	4,086	4,026
Net Income / (Loss) Continuing Operations	3,778	5,372	6,782	5,420	8,489	5,120	2,646	2,232	1,843
Consolidated Net Income / (Loss)	3,778	5,372	6,782	5,420	8,489	5,120	2,646	2,232	1,843
Depreciation Expense	2,775	3,035	2,937	2,923	2,802	3,651	695	566	610
Non-Cash Adjustments to Reconcile Net Income	2,713	1,577	585	1,904	-4,153	-367	-761	119	-169
Changes in Operating Assets and Liabilities, net	1,097	1,829	-1,648	-3,056	3,212	1,081	1,190	1,169	1,742
Net Cash From Investing Activities	-2,102	-5,174	3,098	-3,611	2,976	-734	-26,378	-1,703	-2,574
Net Cash From Continuing Investing Activities	-2,102	-5,174	3,098	-3,611	2,976	-734	-26,378	-1,703	-2,574
Purchase of Property, Leasehold Improvements and Equipment	-1,406	-1,573	-1,295	-1,154	-1,094	-1,050	-	-471	-461
Purchase of Investment Securities	-3,852	-6,436	-4,650	-8,267	-6,918	-6,506	-31,821	-7,332	-7,159
Divestitures	521	13	4,835	-61	5,592	0.00	0.00	-	-
Sale and/or Maturity of Investments	2,635	2,822	4,208	5,871	5,396	6,822	5,755	6,100	5,046
Net Cash From Financing Activities	-7,647	-4,294	-11,240	-8,212	-8,533	-7,187	23,515	-2,651	-225
Net Cash From Continuing Financing Activities	-7,647	-4,294	-11,240	-8,212	-8,533	-7,187	23,515	-2,651	-225
Issuance of Debt	4,462	1,491	0.00	5,235	4,863	-681	24,343	1,661	0.00
Issuance of Common Equity	305	187	389	326	376	224	68	131	36
Repayment of Debt	-3,402	-1,769	-2,559	-4,714	-9,599	-4,494	-131	-1,563	-148
Repurchase of Common Equity	-7,034	-2,284	-7,607	-7,742	-4,042	-1,987	-342	-2,725	-139
Payment of Dividends	-1,567	-1,450	-1,384	-1,341	-15	-15	-	0.00	0.00
Other Financing Activities, Net	-411	-469	-79	24	-116	-234	-423	-155	26
Effect of Exchange Rate Changes	-20	16	-86	-65	41	-	-	55	-10
Cash Interest Paid	1,342	1,330	1,229	1,253	1,439	1,645	267	240	244
Cash Income Taxes Paid	898	1,471	1,850	2,240	1,837	1,776	1,019	1,036	1,064

This table details how cash moves in and out of The Cigna Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-555	1,747	-273	-2,687	1,807	-209	-1,090	1,647	2,013	-1,141	2,194
Net Cash From Operating Activities	1,920	5,212	46	265	4,840	1,467	2,826	2,492	5,028	2,099	3,283
Net Cash From Continuing Operating Activities	1,920	5,212	46	265	4,840	1,467	2,826	2,492	5,028	2,099	3,283
Net Income / (Loss) Continuing Operations	1,409	1,536	825	1,629	-212	1,107	1,449	1,510	1,306	1,222	2,778
Consolidated Net Income / (Loss)	1,409	1,536	825	1,629	-212	1,107	1,449	1,510	1,306	1,222	2,778
Depreciation Expense	674	646	650	738	741	765	766	755	749	735	726
Non-Cash Adjustments to Reconcile Net Income	96	-9,177	9,987	48	1,855	-738	738	982	595	459	-285
Changes in Operating Assets and Liabilities, net	-259	12,207	-11,416	-2,150	2,456	333	-127	-755	2,378	-317	64
Net Cash From Investing Activities	1,197	-191	-776	-640	-495	-440	-1,337	-414	-2,983	-616	4,446
Net Cash From Continuing Investing Activities	1,197	-191	-776	-640	-495	-440	-1,337	-414	-2,983	-616	4,446
Purchase of Property, Leasehold Improvements and Equipment	-327	-337	-399	-370	-300	-	-	-397	-408	-345	-338
Purchase of Investment Securities	-1,554	-1,695	-747	-492	-918	111	-2,385	-948	-3,214	-967	-726
Divestitures	2,346	521	-	-	0.00	-	-14	5.00	22	-3.00	4,895
Sale and/or Maturity of Investments	732	1,320	370	222	723	928	351	926	617	699	615
Net Cash From Financing Activities	-3,681	-3,248	439	-2,309	-2,529	-1,250	-2,572	-435	-37	-2,636	-5,517
Net Cash From Continuing Financing Activities	-3,681	-3,248	439	-2,309	-2,529	-1,250	-2,572	-435	-37	-2,636	-5,517
Issuance of Debt	0.00	-366	366	-	4,462	-1,484	1,301	183	1,491	-	-
Issuance of Common Equity	69	22	62	40	181	74	54	29	30	72	100
Repayment of Debt	-1,591	-402	467	-893	-2,574	1,198	-2,887	9.00	-89	-508	-1,807
Repurchase of Common Equity	-1,508	-2,022	-	-990	-4,022	-544	-624	-154	-962	-1,733	-3,500
Payment of Dividends	-412	-384	-390	-392	-401	-358	-362	-362	-368	-334	-341
Other Financing Activities, Net	-239	-96	-66	-74	-175	-136	-54	-140	-139	-133	31
Effect of Exchange Rate Changes	9.00	-26	18	-3.00	-9.00	-	-	-	5.00	12	-18
Cash Interest Paid	379	305	394	307	336	311	387	310	322	306	308
Cash Income Taxes Paid	140	59	272	457	110	91	454	849	77	504	435

This table presents The Cigna Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Total Assets	155,881	152,761	143,885	154,889	155,451	155,774	153,226	61,759
Cash and Due from Banks	7,550	7,822	5,924	5,081	10,182	4,619	3,855	2,972
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	3,654	3,695	3,774	3,692	4,205	4,417	4,562	1,563
Separate Account Business Assets	7,278	7,430	7,278	8,337	9,086	8,465	7,839	8,423
Goodwill	44,370	44,259	45,811	45,811	44,648	44,602	44,505	6,164
Intangible Assets	29,417	30,863	32,492	34,102	35,179	36,562	39,003	345
Other Assets	63,612	58,692	48,606	57,866	48,766	54,151	50,641	40,055
Total Liabilities & Shareholders' Equity	155,881	152,761	143,885	154,889	155,451	155,774	153,226	61,759
Total Liabilities	114,638	106,410	99,131	107,705	105,065	110,395	112,154	47,999
Short-Term Debt	12,329	36,657	10,768	24,509	8,852	10,604	24,824	424
Accrued Interest Payable	9,387	9,955	7,978	7,322	8,515	7,347	7,071	3,963
Other Short-Term Payables	36,263	2,104	22,479	11,741	18,655	22,187	0.00	6,622
Long-Term Debt	28,937	28,155	28,100	31,125	29,545	31,893	39,523	5,199
Separate Account Business Liabilities	7,278	7,430	7,278	8,337	9,086	8,465	7,839	8,423
Other Long-Term Liabilities	20,444	22,109	22,528	24,671	30,412	29,899	32,897	23,368
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.00	107	66	54	58	35	37	49
Total Equity & Noncontrolling Interests	41,243	46,244	44,688	47,130	50,328	45,344	41,035	13,711
Total Preferred & Common Equity	41,033	46,223	44,675	47,112	50,321	45,338	41,028	13,711
Total Common Equity	41,033	46,223	44,675	47,112	50,321	45,338	41,028	13,711
Common Stock	31,292	30,673	30,237	29,578	28,979	28,310	27,755	3,014
Retained Earnings	43,519	41,652	37,940	32,593	28,575	20,162	15,088	15,800
Treasury Stock	-31,437	-24,238	-21,844	-14,175	-6,372	-2,193	-104	-4,021
Accumulated Other Comprehensive Income / (Loss)	-2,341	-1,864	-1,658	-884	-861	-941	-1,711	-1,082
Noncontrolling Interest	210	21	13	18	7.00	6.00	7.00	0.00

This table presents The Cigna Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	150,658	155,881	157,639	155,446	153,119	152,761	149,645	150,054	147,976	143,885	144,209
Cash and Due from Banks	8,334	7,550	5,888	6,788	8,439	7,822	8,497	9,585	7,935	5,924	7,079
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	3,681	3,654	3,594	3,551	3,607	3,695	3,924	3,884	3,837	3,774	3,744
Separate Account Business Assets	7,277	7,278	7,651	7,431	7,416	7,430	7,028	7,324	7,340	7,278	7,260
Goodwill	44,372	44,370	44,374	44,258	44,258	44,259	45,810	45,811	45,811	45,811	45,807
Intangible Assets	29,045	29,417	29,791	30,176	30,491	30,863	31,324	31,713	32,102	32,492	32,885
Other Assets	57,949	63,612	66,341	63,242	58,908	58,692	53,062	51,737	50,951	48,606	46,670
Total Liabilities & Shareholders' Equity	150,658	155,881	157,639	155,446	153,119	152,761	149,645	150,054	147,976	143,885	144,209
Total Liabilities	110,244	114,638	115,341	113,919	111,769	106,410	103,879	104,528	103,380	99,131	99,076
Short-Term Debt	47,713	12,329	45,365	10,992	39,905	36,657	10,719	31,307	28,387	10,768	10,358
Accrued Interest Payable	8,032	9,387	8,920	9,003	8,857	9,955	9,668	8,499	9,174	7,978	7,986
Other Short-Term Payables	0.00	36,263	2,775	35,378	3,215	2,104	26,672	7,539	7,166	22,479	22,771
Long-Term Debt	26,455	28,937	30,230	30,175	31,053	28,155	28,094	28,115	29,124	28,100	28,090
Separate Account Business Liabilities	7,277	7,278	7,651	7,431	7,416	7,430	7,028	7,324	7,340	7,278	7,260
Other Long-Term Liabilities	20,767	20,444	20,400	20,940	21,323	22,109	21,698	21,744	22,189	22,528	22,611
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	40,414	41,243	42,298	41,527	41,350	46,244	45,702	45,464	44,518	44,688	45,083
Total Preferred & Common Equity	40,226	41,033	42,095	41,332	41,181	46,223	45,691	45,445	44,502	44,675	45,041
Total Common Equity	40,226	41,033	42,095	41,332	41,181	46,223	45,691	45,445	44,502	44,675	45,041
Common Stock	31,447	31,292	31,190	31,052	30,296	30,673	30,567	30,440	30,336	30,237	29,399
Retained Earnings	44,434	43,519	42,480	42,132	40,978	41,652	40,982	39,936	38,841	37,940	37,041
Treasury Stock	-33,065	-31,437	-29,412	-29,410	-27,769	-24,238	-23,739	-23,053	-22,906	-21,844	-19,390
Accumulated Other Comprehensive Income / (Loss)	-2,590	-2,341	-2,163	-2,442	-2,324	-1,864	-2,119	-1,878	-1,769	-1,658	-2,009
Noncontrolling Interest	188	210	203	195	169	21	11	19	16	13	42

This table displays calculated financial ratios and metrics derived from The Cigna Group's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	26.19%	6.60%	4.35%	5.82%	7.03%	216.54%	16.41%	4.73%	0.00%
EBITDA Growth	-5.15%	-20.44%	15.03%	-27.71%	26.93%	149.33%	7.91%	23.27%	0.00%
EBIT Growth	-3.66%	-27.70%	20.34%	-35.01%	49.13%	102.30%	5.73%	29.51%	0.00%
NOPAT Growth	-29.11%	-12.77%	21.77%	-33.58%	49.47%	113.37%	26.21%	29.57%	0.00%
Net Income Growth	-29.67%	-20.79%	25.13%	-36.15%	65.80%	93.50%	18.55%	21.11%	0.00%
EPS Growth	-30.30%	-18.78%	35.94%	-31.40%	70.83%	27.51%	20.18%	21.98%	0.00%
Operating Cash Flow Growth	-12.27%	36.47%	20.37%	-30.52%	9.12%	151.59%	-7.73%	1.49%	0.00%
Free Cash Flow Firm Growth	261.18%	-176.97%	452.51%	-187.89%	-63.69%	128.88%	-388.51%	0.00%	0.00%
Invested Capital Growth	-25.78%	32.94%	-18.67%	15.81%	1.03%	-16.64%	443.87%	0.00%	0.00%
Revenue Q/Q Growth	7.12%	2.24%	-0.28%	-0.12%	4.93%	18.61%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	21.92%	-12.31%	2.95%	-27.16%	34.19%	17.91%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	37.35%	-17.08%	3.98%	-33.90%	49.29%	16.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	1.39%	23.58%	16.06%	-32.06%	47.67%	16.86%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	12.81%	-2.10%	1.25%	-35.66%	59.24%	19.54%	0.00%	0.00%	0.00%
EPS Q/Q Growth	14.34%	-1.86%	2.00%	-33.40%	60.90%	19.79%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	56.59%	-5.08%	-20.09%	-0.26%	16.96%	39.12%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	217.11%	-562.46%	6.70%	-128.26%	71.15%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-30.01%	31.43%	0.05%	0.65%	-0.70%	-0.13%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
EBITDA Margin	3.88%	5.16%	6.91%	6.27%	9.18%	7.74%	9.83%	10.60%	9.01%
EBIT Margin	2.74%	3.59%	5.30%	4.59%	7.48%	5.37%	8.40%	9.25%	7.48%
Profit (Net Income) Margin	1.55%	2.77%	3.73%	3.11%	5.16%	3.33%	5.45%	5.35%	4.63%
Tax Burden Percent	71.70%	97.44%	80.77%	79.82%	78.11%	77.93%	73.89%	61.90%	61.87%
Interest Burden Percent	78.59%	79.22%	87.24%	84.90%	88.31%	79.62%	87.79%	93.47%	100.00%
Effective Tax Rate	28.30%	2.56%	19.23%	20.18%	21.89%	22.07%	26.11%	38.10%	38.13%
Return on Invested Capital (ROIC)	4.96%	6.96%	8.34%	6.66%	10.88%	6.65%	4.83%	24.64%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	3.02%	4.24%	6.24%	4.61%	8.11%	4.20%	3.78%	19.09%	0.00%
Return on Net Nonoperating Assets (RNNOA)	3.66%	4.83%	6.41%	4.45%	6.85%	5.19%	4.82%	7.80%	0.00%
Return on Equity (ROE)	8.63%	11.79%	14.75%	11.11%	17.73%	11.84%	9.65%	32.44%	0.00%
Cash Return on Invested Capital (CROIC)	34.55%	-21.32%	28.93%	-7.99%	9.86%	24.81%	-133.05%	-175.36%	0.00%
Operating Return on Assets (OROA)	4.34%	4.69%	6.44%	5.15%	7.91%	5.34%	3.79%	6.25%	0.00%
Return on Assets (ROA)	2.45%	3.62%	4.54%	3.49%	5.46%	3.31%	2.46%	3.61%	0.00%
Return on Common Equity (ROCE)	8.59%	11.77%	14.73%	11.09%	17.71%	11.83%	9.63%	32.33%	0.00%
Return on Equity Simple (ROE_SIMPLE)	9.21%	11.62%	15.18%	11.50%	16.87%	11.29%	6.45%	16.28%	0.00%
Net Operating Profit after Tax (NOPAT)	4,807	6,781	7,774	6,384	9,612	6,431	3,014	2,388	1,843
NOPAT Margin	1.97%	3.50%	4.28%	3.67%	5.84%	4.18%	6.21%	5.72%	4.63%
Net Nonoperating Expense Percent (NNEP)	1.94%	2.72%	2.10%	2.05%	2.78%	2.45%	1.05%	5.55%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	97.26%	96.41%	94.70%	95.41%	92.52%	94.63%	91.60%	90.75%	92.52%
Earnings before Interest and Taxes (EBIT)	6,704	6,959	9,625	7,998	12,306	8,252	4,079	3,858	2,979
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	9,479	9,994	12,562	10,921	15,108	11,903	4,774	4,424	3,589
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.87	1.87	2.19	1.55	1.41	1.59	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.31	0.45	0.54	0.42	0.43	0.47	0.00	0.00	0.00
Price to Earnings (P/E)	22.37	16.69	14.60	13.63	8.40	14.14	0.00	0.00	0.00
Dividend Yield	2.03%	1.67%	1.40%	1.81%	0.02%	0.02%	0.02%	0.02%	0.03%
Earnings Yield	4.47%	5.99%	6.85%	7.33%	11.90%	7.07%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.34	1.29	1.57	1.20	1.12	1.25	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.45	0.74	0.72	0.71	0.60	0.72	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	11.68	14.34	10.42	11.34	6.58	9.25	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	16.52	20.60	13.60	15.48	8.07	13.34	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	23.04	21.14	16.84	19.40	10.34	17.12	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	10.69	12.13	15.12	17.22	9.60	11.60	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	3.31	0.00	4.85	0.00	11.41	4.59	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	1.00	1.40	0.87	1.18	0.76	0.94	1.57	0.41	0.00
Long-Term Debt to Equity	0.70	0.61	0.63	0.66	0.59	0.70	0.96	0.38	0.00
Financial Leverage	1.21	1.14	1.03	0.96	0.84	1.24	1.28	0.41	0.00
Leverage Ratio	3.52	3.26	3.25	3.18	3.25	3.57	3.92	4.49	0.00
Compound Leverage Factor	2.77	2.58	2.84	2.70	2.87	2.85	3.44	4.20	0.00
Debt to Total Capital	50.01%	58.30%	46.48%	54.11%	43.25%	48.36%	61.04%	29.01%	0.00%
Short-Term Debt to Total Capital	14.94%	32.98%	12.88%	23.84%	9.97%	12.07%	23.55%	2.19%	0.00%
Long-Term Debt to Total Capital	35.07%	25.33%	33.60%	30.27%	33.28%	36.29%	37.49%	26.82%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.25%	0.12%	0.09%	0.07%	0.07%	0.05%	0.04%	0.25%	0.00%
Common Equity to Total Capital	49.73%	41.58%	53.42%	45.82%	56.68%	51.59%	38.92%	70.74%	0.00%
Debt to EBITDA	4.35	6.49	3.09	5.09	2.54	3.57	13.48	1.27	0.00
Net Debt to EBITDA	3.56	5.70	2.62	4.63	1.87	3.18	12.67	0.60	0.00
Long-Term Debt to EBITDA	3.05	2.82	2.24	2.85	1.96	2.68	8.28	1.18	0.00
Debt to NOPAT	8.58	9.56	5.00	8.71	3.99	6.61	21.35	2.35	0.00
Net Debt to NOPAT	7.01	8.40	4.24	7.92	2.94	5.89	20.07	1.11	0.00
Long-Term Debt to NOPAT	6.02	4.15	3.61	4.88	3.07	4.96	13.11	2.18	0.00
Noncontrolling Interest Sharing Ratio	0.39%	0.23%	0.16%	0.14%	0.11%	0.10%	0.17%	0.36%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	33,461	-20,760	26,970	-7,651	8,705	23,974	-83,022	-16,995	0.00
Operating Cash Flow to CapEx	737.06%	750.99%	668.42%	623.14%	946.07%	903.33%	0.00%	867.52%	873.32%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	1.58	1.31	1.22	1.12	1.06	1.00	0.45	0.68	0.00
Fixed Asset Turnover	66.51	51.86	48.67	44.10	38.17	34.24	15.86	26.69	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	82,509	111,163	83,622	102,818	88,783	87,876	105,419	19,383	0.00
Invested Capital Turnover	2.52	1.99	1.95	1.82	1.86	1.59	0.78	4.31	0.00
Increase / (Decrease) in Invested Capital	-28,654	27,541	-19,196	14,035	907	-17,543	86,036	19,383	0.00
Enterprise Value (EV)	110,735	143,326	130,900	123,844	99,356	110,070	0.00	0.00	0.00
Market Capitalization	76,809	86,208	97,877	73,219	71,076	72,151	0.00	0.00	0.00
Book Value per Share	$147.52	$157.96	$146.12	$142.15	$139.29	$121.41	$166.31	$54.65	$0.00
Tangible Book Value per Share	($117.76)	($98.76)	($109.99)	($98.97)	($81.67)	($95.94)	($172.19)	$28.71	$0.00
Total Capital	82,509	111,163	83,622	102,818	88,783	87,876	105,419	19,383	0.00
Total Debt	41,266	64,812	38,868	55,634	38,397	42,497	64,347	5,623	0.00
Total Long-Term Debt	28,937	28,155	28,100	31,125	29,545	31,893	39,523	5,199	0.00
Net Debt	33,716	56,990	32,944	50,553	28,215	37,878	60,492	2,651	0.00
Capital Expenditures (CapEx)	1,406	1,573	1,295	1,154	1,094	1,050	0.00	471	461
Net Nonoperating Expense (NNE)	1,029	1,409	992	964	1,123	1,311	368	156	0.00
Net Nonoperating Obligations (NNO)	41,266	64,812	38,868	55,634	38,397	42,497	64,347	5,623	0.00
Total Depreciation and Amortization (D&A)	2,775	3,035	2,937	2,923	2,802	3,651	695	566	610
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$12.25	$17.57	$21.54	$15.87	$23.17	$13.58	$10.69	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	273.68M	292.36M	297.06M	320.95M	351.85M	372.04M	380.06M	0.00	0.00
Adjusted Diluted Earnings per Share	$12.12	$17.39	$21.30	$15.73	$22.96	$13.44	$10.54	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	273.68M	292.36M	297.06M	320.95M	351.85M	372.04M	380.06M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$13.58	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	273.68M	292.36M	297.06M	320.95M	351.85M	372.04M	380.06M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	4,807	6,781	7,774	6,384	9,612	6,431	3,014	2,388	1,843
Normalized NOPAT Margin	1.97%	3.50%	4.28%	3.67%	5.84%	4.18%	6.21%	5.72%	4.63%
Pre Tax Income Margin	2.16%	2.85%	4.62%	3.90%	6.60%	4.27%	7.37%	8.64%	7.48%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	41.48%	26.99%	20.41%	24.74%	0.18%	0.29%	0.00%	0.00%	0.00%
Augmented Payout Ratio	227.66%	69.51%	132.57%	167.58%	47.79%	39.10%	12.93%	122.09%	7.54%

This table displays calculated financial ratios and metrics derived from The Cigna Group's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.51%	32.75%	27.90%	24.40%	19.24%	9.34%	4.43%	7.10%	5.58%	-1.12%	5.97%
EBITDA Growth	135.03%	129.78%	-25.35%	3.33%	-57.83%	-51.66%	-34.28%	-1.28%	18.56%	15.28%	46.03%
EBIT Growth	401.25%	332.66%	-28.89%	5.21%	-79.53%	-72.34%	-41.90%	-1.53%	25.02%	22.81%	60.67%
NOPAT Growth	259.70%	-43.82%	-37.50%	7.51%	-167.34%	164.06%	-42.50%	-0.42%	31.85%	-12.12%	61.01%
Net Income Growth	764.62%	38.75%	-43.06%	7.88%	-116.23%	-9.41%	-47.84%	-3.82%	7.76%	7.38%	69.91%
EPS Growth	600.00%	43.55%	-44.51%	10.77%	-122.88%	-8.64%	-47.16%	0.61%	13.67%	12.35%	86.88%
Operating Cash Flow Growth	-60.33%	255.28%	-98.37%	-89.37%	-3.74%	-30.11%	-13.92%	100.32%	147.68%	-50.90%	54.93%
Free Cash Flow Firm Growth	95.07%	225.30%	-4,464.45%	245.22%	22.37%	-219.08%	-96.58%	-196.06%	-198.04%	261.48%	298.65%
Invested Capital Growth	2.02%	-25.78%	39.39%	-21.20%	9.99%	32.94%	1.19%	21.34%	18.75%	-18.67%	-18.19%
Revenue Q/Q Growth	-0.46%	5.04%	3.66%	9.16%	11.82%	1.20%	0.82%	4.63%	2.42%	-3.35%	3.40%
EBITDA Q/Q Growth	-11.04%	36.02%	-28.50%	171.63%	-31.66%	-55.81%	-1.03%	10.86%	-0.29%	-39.92%	48.67%
EBIT Q/Q Growth	-15.23%	51.21%	-33.67%	489.53%	-55.74%	-75.15%	-1.87%	14.70%	-1.11%	-47.80%	66.30%
NOPAT Q/Q Growth	-5.20%	67.04%	-43.95%	279.92%	-197.21%	85.83%	-3.58%	12.70%	30.77%	-59.54%	66.98%
Net Income Q/Q Growth	-8.27%	86.18%	-49.36%	868.40%	-119.15%	-23.60%	-4.04%	15.62%	6.87%	-56.01%	76.94%
EPS Q/Q Growth	-3.19%	90.49%	-51.74%	661.86%	-127.79%	-26.37%	-3.66%	16.04%	10.99%	-57.41%	83.44%
Operating Cash Flow Q/Q Growth	-63.16%	11,230.43%	-82.64%	-94.52%	229.93%	-48.09%	13.40%	-50.44%	139.54%	-36.06%	163.91%
Free Cash Flow Firm Q/Q Growth	-101.82%	194.53%	-233.23%	314.51%	57.34%	-3,392.66%	104.43%	-14.66%	-171.15%	-5.46%	24.55%
Invested Capital Q/Q Growth	38.87%	-30.01%	42.57%	-26.37%	1.03%	31.43%	-19.41%	2.78%	22.11%	0.05%	-3.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	4.10%	4.58%	3.54%	5.13%	2.06%	2.65%	6.06%	6.18%	5.83%	5.99%	9.63%
EBIT Margin	3.07%	3.60%	2.50%	3.91%	0.72%	1.10%	4.50%	4.62%	4.22%	4.37%	8.09%
Profit (Net Income) Margin	2.15%	2.33%	1.32%	2.69%	-0.38%	2.23%	2.96%	3.11%	2.81%	2.69%	5.92%
Tax Burden Percent	85.50%	76.46%	69.21%	81.90%	-268.35%	588.83%	78.75%	80.15%	81.57%	89.99%	79.58%
Interest Burden Percent	81.99%	84.73%	76.02%	84.14%	19.70%	34.31%	83.45%	83.85%	81.73%	68.55%	91.99%
Effective Tax Rate	14.50%	23.54%	30.79%	18.10%	368.35%	-488.83%	21.25%	19.85%	18.43%	10.01%	20.42%
Return on Invested Capital (ROIC)	5.84%	6.95%	3.90%	7.32%	-3.67%	12.94%	7.98%	7.25%	6.73%	5.25%	12.62%
ROIC Less NNEP Spread (ROIC-NNEP)	5.41%	6.43%	3.45%	6.71%	-2.33%	8.85%	7.24%	6.67%	6.13%	5.25%	12.10%
Return on Net Nonoperating Assets (RNNOA)	9.61%	7.78%	4.48%	7.75%	-3.48%	10.07%	6.15%	7.29%	6.58%	5.40%	12.17%
Return on Equity (ROE)	15.45%	14.73%	8.38%	15.07%	-7.15%	23.01%	14.14%	14.54%	13.31%	10.65%	24.79%
Cash Return on Invested Capital (CROIC)	3.78%	34.55%	-28.22%	29.42%	-4.65%	-21.32%	5.34%	-12.16%	-9.83%	28.93%	27.22%
Operating Return on Assets (OROA)	5.10%	5.70%	3.71%	5.49%	0.97%	1.44%	5.80%	5.72%	5.17%	5.31%	9.87%
Return on Assets (ROA)	3.58%	3.69%	1.95%	3.78%	-0.52%	2.91%	3.81%	3.85%	3.44%	3.28%	7.23%
Return on Common Equity (ROCE)	15.38%	14.67%	8.35%	15.02%	-7.13%	22.95%	14.11%	14.51%	13.29%	10.63%	24.75%
Return on Equity Simple (ROE_SIMPLE)	13.42%	0.00%	7.96%	9.61%	9.36%	0.00%	12.01%	15.00%	15.45%	0.00%	14.87%
Net Operating Profit after Tax (NOPAT)	1,719	1,813	1,085	1,936	-1,076	3,227	1,736	1,801	1,598	1,222	3,020
NOPAT Margin	2.62%	2.75%	1.73%	3.20%	-1.94%	6.51%	3.54%	3.70%	3.44%	2.69%	6.43%
Net Nonoperating Expense Percent (NNEP)	0.43%	0.52%	0.45%	0.61%	-1.35%	4.09%	0.74%	0.58%	0.60%	0.00%	0.52%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	96.93%	96.40%	97.50%	96.09%	99.28%	98.90%	95.50%	95.38%	95.78%	95.63%	91.91%
Earnings before Interest and Taxes (EBIT)	2,010	2,371	1,568	2,364	401	548	2,205	2,247	1,959	1,981	3,795
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,684	3,017	2,218	3,102	1,142	1,313	2,971	3,002	2,708	2,716	4,521
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.24	1.87	2.30	2.27	2.58	1.87	1.82	1.80	1.68	2.19	1.83
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.36	0.31	0.42	0.44	0.52	0.45	0.44	0.44	0.40	0.54	0.45
Price to Earnings (P/E)	17.89	22.37	31.87	25.33	29.33	16.69	15.63	12.22	11.01	14.60	12.44
Dividend Yield	1.74%	2.03%	1.57%	1.59%	1.40%	1.67%	1.71%	1.70%	1.83%	1.40%	1.61%
Earnings Yield	5.59%	4.47%	3.14%	3.95%	3.41%	5.99%	6.40%	8.18%	9.09%	6.85%	8.04%
Enterprise Value to Invested Capital (EV/IC)	1.36	1.34	1.41	1.55	1.50	1.29	1.34	1.25	1.22	1.57	1.36
Enterprise Value to Revenue (EV/Rev)	0.62	0.45	0.73	0.60	0.83	0.74	0.60	0.70	0.67	0.72	0.63
Enterprise Value to EBITDA (EV/EBITDA)	14.16	11.68	21.45	15.07	20.04	14.34	9.97	10.16	9.57	10.42	9.34
Enterprise Value to EBIT (EV/EBIT)	18.77	16.52	34.16	23.28	31.27	20.60	13.54	13.17	12.40	13.60	12.31
Enterprise Value to NOPAT (EV/NOPAT)	23.78	23.04	35.17	24.00	32.38	21.14	20.71	19.29	18.07	16.84	17.02
Enterprise Value to Operating Cash Flow (EV/OCF)	20.97	10.69	25.20	13.67	14.53	12.13	9.13	10.19	10.66	15.12	10.52
Enterprise Value to Free Cash Flow (EV/FCFF)	36.38	3.31	0.00	4.65	0.00	0.00	25.32	0.00	0.00	4.85	4.51
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.84	1.00	1.79	0.99	1.72	1.40	0.85	1.31	1.29	0.87	0.85
Long-Term Debt to Equity	0.65	0.70	0.71	0.73	0.75	0.61	0.61	0.62	0.65	0.63	0.62
Financial Leverage	1.77	1.21	1.30	1.16	1.49	1.14	0.85	1.09	1.07	1.03	1.01
Leverage Ratio	3.72	3.52	3.49	3.51	3.50	3.26	3.23	3.31	3.31	3.25	3.22
Compound Leverage Factor	3.05	2.99	2.65	2.95	0.69	1.12	2.70	2.77	2.71	2.23	2.96
Debt to Total Capital	64.73%	50.01%	64.12%	49.78%	63.18%	58.30%	45.89%	56.62%	56.32%	46.48%	46.00%
Short-Term Debt to Total Capital	41.64%	14.94%	38.48%	13.29%	35.53%	32.98%	12.67%	29.83%	27.80%	12.88%	12.39%
Long-Term Debt to Total Capital	23.09%	35.07%	25.64%	36.49%	27.65%	25.33%	33.22%	26.79%	28.52%	33.60%	33.61%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.16%	0.25%	0.17%	0.24%	0.15%	0.12%	0.09%	0.08%	0.09%	0.09%	0.11%
Common Equity to Total Capital	35.11%	49.73%	35.71%	49.98%	36.67%	41.58%	54.02%	43.30%	43.58%	53.42%	53.89%
Debt to EBITDA	6.73	4.35	9.72	4.83	8.42	6.49	3.41	4.59	4.43	3.09	3.15
Net Debt to EBITDA	5.97	3.56	8.97	4.03	7.42	5.70	2.66	3.85	3.82	2.62	2.57
Long-Term Debt to EBITDA	2.40	3.05	3.89	3.54	3.68	2.82	2.47	2.17	2.24	2.24	2.30
Debt to NOPAT	11.30	8.58	15.95	7.69	13.61	9.56	7.07	8.72	8.36	5.00	5.74
Net Debt to NOPAT	10.03	7.01	14.70	6.42	11.99	8.40	5.53	7.31	7.21	4.24	4.68
Long-Term Debt to NOPAT	4.03	6.02	6.38	5.64	5.95	4.15	5.12	4.12	4.24	3.61	4.19
Noncontrolling Interest Sharing Ratio	0.44%	0.39%	0.32%	0.32%	0.31%	0.23%	0.18%	0.17%	0.19%	0.16%	0.17%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-555	30,467	-32,229	24,190	-11,277	-24,314	738	-16,657	-14,527	20,418	21,598
Operating Cash Flow to CapEx	587.16%	1,546.59%	11.53%	71.62%	1,613.33%	0.00%	0.00%	627.71%	1,232.35%	608.41%	971.30%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.66	1.58	1.49	1.40	1.35	1.31	1.29	1.24	1.23	1.22	1.22
Fixed Asset Turnover	69.35	66.51	60.70	57.70	54.44	51.86	49.41	49.68	49.12	48.67	46.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	114,582	82,509	117,893	82,694	112,308	111,163	84,579	104,948	102,107	83,622	83,581
Invested Capital Turnover	2.23	2.52	2.25	2.29	1.89	1.99	2.25	1.96	1.96	1.95	1.96
Increase / (Decrease) in Invested Capital	2,274	-28,654	33,314	-22,254	10,201	27,541	998	18,458	16,125	-19,196	-18,578
Enterprise Value (EV)	156,062	110,735	166,757	128,480	168,868	143,326	113,651	131,506	124,223	130,900	113,973
Market Capitalization	90,040	76,809	96,847	93,906	106,180	86,208	83,260	81,588	74,553	97,877	82,512
Book Value per Share	$146.98	$147.52	$150.58	$145.50	$140.86	$157.96	$154.37	$153.60	$149.81	$146.12	$147.62
Tangible Book Value per Share	($121.28)	($117.76)	($114.72)	($116.53)	($114.82)	($98.76)	($106.23)	($108.42)	($112.47)	($109.99)	($110.29)
Total Capital	114,582	82,509	117,893	82,694	112,308	111,163	84,579	104,948	102,107	83,622	83,581
Total Debt	74,168	41,266	75,595	41,167	70,958	64,812	38,813	59,422	57,511	38,868	38,448
Total Long-Term Debt	26,455	28,937	30,230	30,175	31,053	28,155	28,094	28,115	29,124	28,100	28,090
Net Debt	65,834	33,716	69,707	34,379	62,519	56,990	30,316	49,837	49,576	32,944	31,369
Capital Expenditures (CapEx)	327	337	399	370	300	0.00	0.00	397	408	345	338
Net Nonoperating Expense (NNE)	310	277	260	307	-864	2,120	287	291	292	0.00	242
Net Nonoperating Obligations (NNO)	74,168	41,266	75,595	41,167	70,958	64,812	38,813	59,422	57,511	38,868	38,448
Total Depreciation and Amortization (D&A)	674	646	650	738	741	765	766	755	749	735	726
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.88	$5.06	$2.65	$5.51	($0.97)	$3.54	$4.79	$4.96	$4.28	$3.89	$9.07
Adjusted Weighted Average Basic Shares Outstanding	267.14M	273.68M	278.15M	279.55M	284.07M	292.36M	292.62M	295.98M	295.87M	297.06M	305.74M
Adjusted Diluted Earnings per Share	$4.85	$5.01	$2.63	$5.45	($0.97)	$3.49	$4.74	$4.92	$4.24	$3.82	$8.97
Adjusted Weighted Average Diluted Shares Outstanding	267.14M	273.68M	278.15M	279.55M	284.07M	292.36M	292.62M	295.98M	295.87M	297.06M	305.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	267.14M	273.68M	278.15M	279.55M	284.07M	292.36M	292.62M	295.98M	295.87M	297.06M	305.74M
Normalized Net Operating Profit after Tax (NOPAT)	1,720	1,813	1,085	1,936	281	384	1,736	1,801	1,598	1,222	3,020
Normalized NOPAT Margin	2.62%	2.75%	1.73%	3.20%	0.51%	0.77%	3.54%	3.70%	3.44%	2.69%	6.43%
Pre Tax Income Margin	2.51%	3.05%	1.90%	3.29%	0.14%	0.38%	3.75%	3.88%	3.45%	2.99%	7.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	29.23%	41.48%	46.01%	38.08%	38.48%	26.99%	25.99%	20.61%	20.29%	20.41%	20.51%
Augmented Payout Ratio	112.95%	227.66%	211.91%	193.63%	177.14%	69.51%	89.28%	113.76%	125.01%	132.57%	129.43%

Frequently Asked Questions About The Cigna Group's Financials

When does The Cigna Group's fiscal year end?

According to the most recent income statement we have on file, The Cigna Group's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has The Cigna Group's net income changed over the last 8 years?

The Cigna Group's net income appears to be on an upward trend, with a most recent value of $3.78 billion in 2024, rising from $1.84 billion in 2016. The previous period was $5.37 billion in 2023. See The Cigna Group's forecast for analyst expectations on what’s next for the company.

How has The Cigna Group revenue changed over the last 8 years?

Over the last 8 years, The Cigna Group's total revenue changed from $39.84 billion in 2016 to $244.41 billion in 2024, a change of 513.5%.

How much debt does The Cigna Group have?

The Cigna Group's total liabilities were at $114.64 billion at the end of 2024, a 7.7% increase from 2023, and a 138.8% increase since 2017.

How much cash does The Cigna Group have?

In the past 7 years, The Cigna Group's cash and equivalents has ranged from $2.97 billion in 2017 to $10.18 billion in 2020, and is currently $7.55 billion as of their latest financial filing in 2024.

How has The Cigna Group's book value per share changed over the last 8 years?

Over the last 8 years, The Cigna Group's book value per share changed from 0.00 in 2016 to 147.52 in 2024, a change of 14,752.0%.

Related Companies

This page (NYSE:CI) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Cigna Group (CI) Financials

Frequently Asked Questions About The Cigna Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Cigna Group (CI) Financials

Annual Income Statements for The Cigna Group

Quarterly Income Statements for The Cigna Group

Annual Cash Flow Statements for The Cigna Group

Quarterly Cash Flow Statements for The Cigna Group

Annual Balance Sheets for The Cigna Group

Quarterly Balance Sheets for The Cigna Group

Annual Metrics And Ratios for The Cigna Group

Quarterly Metrics And Ratios for The Cigna Group

Frequently Asked Questions About The Cigna Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools